Operational Intelligence
Powered by
Operational Intelligence A unified view across Quality, Manufacturing, R&D, Regulatory, Supply Chain & Commercial — tracking 12,400 employees, 9 manufacturing sites, 200+ products, and 40+ regulatory markets.
99.4%
Batch Right-First-Time
3.1 days
Median Deviation Closure
Illustrative operational report generated by Computer, by DevRev · Data period: May 1 – Jun 28, 2026
Powered by Computer's Intelligence Layer
Four pillars connect Strides' GxP and business systems into a single operational intelligence engine — syncing data, building memory, enforcing permissions, and taking validated actions.
AirSync
Bi-directional sync with GxP & business systems. Real-time ingestion, no ETL.
SAP TrackWise LIMS MES Veeva Salesforce
Memory
Knowledge Graph linking products, batches, sites, deviations & markets.
Products Batches Sites Deviations Filings Suppliers
Actions
Validated skills that triage deviations, draft CAPAs, and generate reports.
Deviation Triage CAPA Drafts Batch Reports Alerts Dashboards
Permissions
GxP-grade access control. Data respects site, role & 21 CFR Part 11 boundaries.
RBAC Part 11 Audit Trail e-Signatures SOC 2 Data Scoping
Output:
Quality Scores
|
Deviation Alerts
|
Site Dashboards
|
Predictive Insights
Enterprise Health at a Glance
Period: May 1 – Jun 28, 2026 | vs previous period (Mar 1 – Apr 30, 2026)
Quality 99.4%
Right-First-Time
+1.6%
Manufacturing 87.2%
Overall Equipment Effectiveness
+4.1%
Supply Chain 96.8%
On-Time-In-Full
+2.3%
Regulatory 100%
On-Time Filings
Maintained
Batch Disposition (60 days) AI Adoption (Computer) 68%
Weekly Active Users
+19% vs Q1
Top: Deviation triage (31%), Batch record search (24%), CAPA drafting (17%), Reports (16%), Filings (12%)
Quality Systems & Deviation Management
9 sites | Deviations, CAPAs, Change Controls, Complaints | eQMS on TrackWise
99.4%
Batch Right-First-Time
+1.6%
3.1 days
Median Deviation Closure
-2.4 days
94.2%
CAPA On-Time Closure
+6.8%
0.28%
Market Complaint Rate
-0.09%
Deviations by Category Process deviations trending down 11% QoQ after line-clearance skill rollout.
Quality Event Aging
AI Deviation Triage 51%
Low-risk deviations auto-classified & routed without manual triage.
Site Quality Scorecard Site Batches RFT Open Dev. CAPA On-Time Audit Readiness Score Bengaluru (Oral Solids) 612 99.6% 42 96% Ready 95 Puducherry (Sterile) 388 99.1% 31 93% Ready 92 Chestnut Ridge (US) 274 99.5% 23 95% Ready 93 Nairobi (ARV) 196 98.7% 16 88% Monitor 84 Singapore (API) 142 99.2% 19 90% Ready 89 East Brunswick (Soft Gel) 130 98.4% 27 82% Monitor 78
Production Throughput & Equipment Effectiveness
9 sites | Oral solids, sterile, soft gel, API | MES-connected lines
4.2 days
Avg Batch Cycle Time
-0.8 days
OEE by Site (%) 91 Bengaluru
85 Puducherry
89 Chestnut R.
77 Nairobi
83 Singapore
71 E. Brunswick
87 Hosur
80 Cuernavaca
OEE Loss Breakdown Changeover is the top loss driver. Rec: AI SMED sequencing skill — target -20% changeover.
Line Performance — Sprint of Batches Line Site Batches OEE Yield RFT Status OSD Line 3 Bengaluru 84 93% 98.4% 99.8% Optimal Sterile Fill A Puducherry 52 86% 97.1% 99.2% Optimal Granulation 2 Chestnut Ridge 61 89% 97.8% 99.5% Optimal Coating Line 1 Nairobi 38 77% 96.2% 98.7% Watch Soft Gel B East Brunswick 29 71% 94.8% 98.4% At Risk
Pipeline Development & Regulatory Filings
Formulation dev, ANDA/dossier filing, 40+ markets | US FDA, EMA, WHO-PQ, MHRA
47
Products in Development
+6
18
Filings Submitted (60d)
+4
100%
On-Time Filings
Maintained
Development Funnel Bottleneck: Pilot/BE stage averages 118 days. Rec: AI protocol drafting to compress by ~3 weeks.
Filings by Market
Query Response Time 11.4 days
Avg agency query turnaround, down from 19 days — AI dossier search.
Key Filing Milestones Product Dosage Market Type Stage Target Date Status Dolutegravir 50mg Tablet WHO-PQ Dossier Filed Aug 2026 On Track Levetiracetam ER Tablet US ANDA Exhibit Sep 2026 On Track Tacrolimus Capsule EU Dossier Pilot/BE Nov 2026 At Risk Sevelamer Tablet US ANDA Formulation Q1 2027 On Track Vitamin D3 Soft Gel Soft Gel Africa Dossier Filed Jul 2026 On Track
Supply Reliability & Inventory Health
200+ SKUs | API & excipient sourcing | 40+ market distribution | SAP-integrated
96.8%
On-Time-In-Full
+2.3%
62 days
Inventory Days on Hand
-7 days
98.1%
Supplier Quality Acceptance
+1.2%
4
Active Stock-Out Risks
+1
Inventory Mix
AI Demand Forecast Accuracy 91.3%
SKU-level forecast MAPE improved from 82% — fewer expedites.
Supplier Risk Tiering 2 single-source APIs flagged Tier 3. Rec: dual-sourcing qualification skill.
Stock-Out Risk Watchlist Material Type Supplier Days Cover Lead Time Market Impact Risk Dolutegravir API API Single-source 18 90 days Africa ARV High HPMC Capsules Packaging Dual 24 45 days Global Medium Tacrolimus API API Single-source 31 75 days EU Medium Microcrystalline Cellulose Excipient Multi 52 30 days Global Low
Commercial Performance & Order Fulfillment
Regulated & emerging markets | B2B tenders, distributors, institutional | Salesforce-integrated
$318M
Revenue (Quarter)
+14%
36.2%
Tender Win Rate
+3.4%
2.4%
Order-to-Cash Disputes
-0.7%
Revenue by Region Africa institutional business up 22% on new WHO-PQ approvals.
Tender Pipeline by Stage (Value) AI tender-scoring skill prioritizes high-fit bids — win rate up 3.4 pts.
Top Commercial Accounts — Quarter Account Segment Region Revenue OTIF Growth Health Global Fund / PEPFAR Institutional Africa $48M 97% +24% Strong US Retail Distributor A B2B US $41M 96% +11% Strong EU Generics Partner B2B Europe $29M 94% +8% Strong LATAM Distributor Emerging LATAM $18M 91% +4% Monitor MENA Tender Board Institutional MENA $14M 88% -2% Monitor
Actionable Recommendations
Computer analyzed 60 days of cross-functional data to surface these insights
Risk Alerts Dolutegravir API — Stock-Out Risk 18 days cover on a single-source API with 90-day lead time. Africa ARV supply exposed. Rec: expedite dual-sourcing qualification + safety stock.
East Brunswick Soft Gel — OEE Decline Line at 71% OEE (site avg 83%), RFT trailing at 98.4%. Changeover losses dominate. Rec: SMED sequencing + preventive maintenance review.
Nairobi CAPA Backlog 88% on-time closure vs 94% target; 4% of events aged >30 days. Rec: CAPA drafting skill + weekly quality council digest.
Efficiency Wins AI Deviation Triage Saves 2,100 hrs/qtr 51% of low-risk deviations auto-classified & routed. At ~4 hrs manual triage each, that is 2,100 QA hours recovered this quarter.
Faster Agency Query Turnaround Query response cut from 19 to 11.4 days via AI dossier search — protecting filing timelines across 40+ markets.
Demand Forecast Accuracy at 91.3% SKU-level MAPE up from 82%, reducing expedite freight and inventory days on hand by 7 days.
Strategic Recommendations 1. Dual-source Tier 3 APIs (Dolutegravir, Tacrolimus) — de-risk ~$60M revenue exposure
2. SMED changeover skill across low-OEE lines — target +5 pts OEE, ~150 extra batches/yr
3. Auto CAPA drafting for Nairobi & East Brunswick — clear aged-event backlog
4. AI protocol drafting for Pilot/BE — compress dev funnel by ~3 weeks
5. Weekly site-quality digests per plant head — replace manual review prep
ROI Summary Deviation triage automation $168K/qtr
OEE recovery (extra batches) $1.2M/qtr
Faster filings (revenue accel.) $2.4M accel.
Inventory optimization (-7 days) $890K freed
Total Quarterly Impact $4.66M
× Operational Intelligence · Powered by Computer, by DevRev
Illustrative data period: May 1 – Jun 28, 2026 | Report generated: Jun 29, 2026
×